• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Prostaglandins & Other Lipid Mediators

    Prostaglandins & Other Lipid Mediators

    JournalISSN 1098-8823eISSN 2212-196X中科院 生物学 3区

    年发文量

    研究主题

    论文(2763)

    排序
    1Resolvin E3 Selectively Enhances EP4 Receptor/gαs Protein-Mediated Camp Signaling Induced by Prostaglandin E2
    Ayaka Hamaguchi,Hayato Fukuda,Mizuki Watanabe,Koichi Fujiwara,Keijo Fukushima,John W. Regan,Asuka Inoue,Satoshi Shuto,Hiromichi Fujino

    Prostaglandin E2 (PGE2) signals through E-type prostanoid (EP) receptors, among which EP4 receptors couple to Gαs protein to induce cAMP formation and also to Gαi protein to induce phosphorylation of extracellular signal-regulated kinases (ERKs). Although PGE2 acts as a pro-inflammatory mediator during the early phase of inflammation, PGE2-activated EP4 receptor signaling has also been implicated in the resolution phase. Resolvin E-series (RvEs), including RvE1, RvE2, and RvE3, are specialized pro-resolving mediators that promote the resolution of inflammation. We previously reported that RvE1 and RvE2, but not RvE3, suppressed cyclooxygenase-2 expression and PGE2 production. Because our previous studies addressed PGE2 production, we herein examined their impact on PGE2-stimulated EP4 receptor-mediated signaling. RvE3, but not RvE1 or RvE2, enhanced PGE2-stimulated cAMP formation, accompanied by increased EP4 receptor-mediated Gαs protein activation. In contrast, RvE3 did not increase Gαi protein activation or phosphorylation of ERKs. Therefore, RvE3 appears to selectively enhance EP4 receptor/Gαs protein-mediated cAMP signaling. Taken together with our previous findings, the present results suggest that RvE3 regulates PGE2-related responses through a mechanism that is distinct from those of RvE1 and RvE2, which may collectively contribute to the resolution of inflammation.

    2026
    引用
    AI阅读
    加入学术空间
    2LPC (18:1) Modulates Seeded Α-Synuclein Aggregation and Associated Cellular Toxicity in a Stable HEK293FT Model.
    T. Tsukahara, H. Haniu,Yoshikazu Matsuda
    2026
    引用
    AI阅读
    加入学术空间
    3Evaluation of Fucoidan-Rich Extract from Sargassum Polycystum As Anticoagulant, Antihyperlipidemic, and Potential Cardioprotective Agent in High-Fat Diet-Induced Wistar Rats
    Destia Risnovanthi,Ayun Dwi Astuti, Ismai Ismail, Eka Kurnia Pla'bistoni, Julianti Citra Rahayu, Renitha Vitha Viona, Ariansyah,Frederika Tangdilintin, Alghifary Anas Ahmad, Wira Bahari Nurdin, Kustiaryah Tarman,Elmi Nurhaidah Zainuddin,

    Fucoidan, a marine polysaccharide, has demonstrated potential in treating cardiovascular diseases, including coronary artery disease (CAD). CAD treatment includes lowering blood coagulation, blood fat levels, and having heart-protective activity. This study aimed to evaluate the potential of fucoidan compounds isolated from brown algae (Sargassum polycystum C. Agardh) on anticoagulant effects through measurements of PT, APTT, and TT, as well as lipid profile, body weight, heart and aortic mass index, LDH, and CK-MB, as well as in Wistar rats (Rattus norvegicus). A total of 36 animals were divided into six groups. Group I received a standard diet without treatment; Group II received 0.5% CMC; Group III was treated with simvastatin at 20 mg/kg BW; and Groups IV, V, and VI received fucoidan at doses of 30 mg/200 g BW, 40 mg/200 g BW, and 50 mg/200 g BW, respectively. Statistical analysis of the lipid profile showed that all fucoidan doses significantly reduced total cholesterol and triglyceride levels, although HDL levels were not increased. Organ weight analysis revealed a significant reduction (p < 0.05) in aortic weight in all treated groups, while no significant changes were observed in body or heart weight. Seven days of fucoidan administration also significantly reduced CK-MB and LDH serum levels (p < 0.05). In conclusion, fucoidan compounds Sargassum polycystum C. Agardh at all tested doses show potential in the treatment of CAD by lowering total cholesterol and triglyceride levels, reducing aortic weight, prolonging coagulation times (PT, APTT, and TT), and decreasing CK-MB and LDH levels.

    2026
    引用
    AI阅读
    加入学术空间
    4Cracking the Code of Cravings: Endocannabinoids and the Hypothalamic Appetite Nexus
    Kajal Bagri,Shilpa Kumari,Rahul Deshmukh

    A complex metabolic condition i.e. obesity is linked to a number of health issues, such as Diabetes, metabolic dysfunctions and cardiovascular disorders etc. Body weight control has often been misunderstood, with eating habits and exercise levels portrayed as personal preferences, usually associated with self-control or lack thereof. However, obesity is more than just a matter of choice in food habits, it is characterized by an excess of macrophage infiltration in adipose tissue, adipocyte hypertrophy, and disruptions in normal metabolic functions. An important contributing factor to the rising prevalence of obesity is disturbed eating patterns, frequently driven by cravings rather than actual hunger. Hypothalamus, particularly the arcuate nucleus plays an important role in regulating hunger and energy homeostasis in the body. The arcuate nucleus regulates appetite through two primary pathways: the orexigenic (appetite-stimulating) and anorexigenic (appetite-suppressing) systems. Remarkably, the endocannabinoid system (ECS) plays a key role in modulating both homeostatic and non-homeostatic aspects of food intake through its cannabinoid receptor 1 and 2 by interacting with various hypothalamic regions controlling hunger feeding patterns of hedonic and reward feeding. This review focuses on the role of ECS control on hypothalamic regulation of appetite, & hedonic or reward feeding patterns. A deeper understanding of these pathways is essential for addressing the growing prevalence of obesity and its associated health risks.

    2026
    引用
    AI阅读
    加入学术空间
    5Lifelong Caloric Restriction Reshapes Age-Related Hepatic Oxylipin Profiles and is Associated with a CYB5R3-Linked Epoxide–Diol Signature
    Lisha Wei, Dehui Sun, Yikai Huang,Xiuke Ouyang, Junyi Zheng, Yang Yu, Chaoting Han, Yu Yang,Jian Hong, Yanyan Zheng

    Caloric restriction (CR) is among the most effective non-genetic strategies to extend lifespan and delay age-related metabolic decline. Yet, the molecular mediators linking CR to hepatic protection remain incompletely understood. Here, we performed age-stratified targeted oxylipin (lipid mediator) profiling of livers from ad libitum (AL) and CR mice across adulthood and aging. In AL-fed mice, similar to 9 months emerged as an inflection point where oxylipin networks shifted toward a pro-inflammatory state, marked by transient elevations in PGE(2), 11-keto-TXB2, 20-HETE, and 5-oxo-ETE, with concomitant loss of pro-resolving/hydroxy-dihydroxylated mediators. Later life was characterized by depletion of CYP-derived epoxides and accumulation of soluble epoxide hydrolase (sEH)-generated diols, indicating impaired epoxide-to-diol coupling and resolution capacity. Lifelong CR dynamically reprogrammed these trajectories, blunting mid-life inflammatory surges, preserving EPA-derived epoxy-fatty acids (eg., EpETEs), and inducing the redox enzyme CYB5R3, which may sustain CYP epoxygenase activity (and epoxide output) despite reduced enzyme abundance. These oxylipin changes coincided with reduced hepatic lipid accumulation and a more favorable systemic metabolic profile in CR mice. Collectively, these findings identify age-and diet-associated remodeling of the hepatic COX/LOX/CYP oxylipin network, particularly the epoxide-diol profile, and nominate CYB5R3-associated redox regulation as a hypothesis for future mechanistic investigation.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2763 篇论文

    高被引作者

    作者引用发文
    Stuart Bunting25612
    Moncada, S.20346
    Charles Nicholas Serhan203323
    John R Vane18584
    John Vane14392
    Makoto Murakami14244
    Rj Gryglewski14083
    Roderick Flower13513
    Salvador Moncada13191
    Ryszard Gryglewski12421

    高产作者

    作者引用发文
    Charles W Weems78630
    Y.S. Weems69528
    Charles Nicholas Serhan203323
    John R Falck97522
    Bruce Hammock105021
    Kenneth V. Honn54718
    Timothy Hla80817
    Darryl Zeldin72217
    Xavier Norel23615
    Michal Laniado Schwartzman59213

    相关期刊

    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
    Biofactors
    Canadian journal of physiology and pharmacology
    Redox report : communications in free radical research
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
    Journal of Physiology and Biochemistry
    Journal of pharmacological sciences
    The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
    Current molecular pharmacology
    Clinical and Experimental Pharmacology and Physiology